Chemotherapeutic engineering: Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivo

Chemical Engineering Science

Volumn 62, Issue 23, 2007, Pages 6641-6648

  Feng, Si Shen ^a   Zhao, Lingyun ^a   Zhang, Zhiping ^a   Bhakta, Gajadhar ^a   Yin Win, Khin ^a   Dong, Yuancai ^a   Chien, Shu ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anticancer drugs; Cancer nanotechnology; Controlled release; Drug delivery; Nanobiotechnology; Nanomedicine; Pharmaceutical nanotechnology; Taxol

Indexed keywords

BIOCOMPATIBILITY; CHEMOTHERAPY; CYTOTOXICITY; DRUG DELIVERY; EMULSIFICATION; ENCAPSULATION; EVAPORATION; MEDICAL NANOTECHNOLOGY; NANOBIOTECHNOLOGY; NANOPARTICLES; SOLVENT EXTRACTION; VITAMINS;

ANTICANCER DRUGS; CANCER NANOTECHNOLOGY; CONTROLLED RELEASE; PHARMACEUTICAL NANOTECHNOLOGY;

BIODEGRADABLE POLYMERS;

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; CHEMOTHERAPY; CYTOTOXICITY; DRUG DELIVERY; EMULSIFICATION; ENCAPSULATION; EVAPORATION; MEDICAL NANOTECHNOLOGY; NANOBIOTECHNOLOGY; NANOPARTICLES; SOLVENT EXTRACTION; VITAMINS;

EID: 35349017895     PISSN: 00092509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ces.2007.08.006     Document Type: Article

References (28)

1. Birnbaum D.T., Kosmala J.D., and Brannon-Peppas L. Optimization of preparation techniques for poly(lactic acid-co-glycolic acid) nanoparticles. Journal of Nanoparticle Research 2 (2000) 173-181
2. Carrio A., Schwach G., Coudane J., and Ver M. Preparation and degradation of surfactant-fee PLAGA microspheres. Journal of Controlled Release 37 (1995) 113-121
3. Crillo-Lopez A.J. Cancer therapies crisis in the USA. Expert Review of Anticancer Therapy 3 (2003) 579-582
4. Engles F.K., Mathot R.A.A., and Verweij J. Alternative drug formulations of decetaxel: a review. Anti-Cancer Drugs 18 (2007) 95-103
5. Feng S.S. Nanoparticles of biodegradable polymers for new concept chemotherapy. Expert Review of Medical Devices 1 (2004) 115-125
6. Feng S.S. New-concept chemotherapy by nanoparticles of biodegradable polymers-where are we now?. Nanomedicine 1 (2006) 297-309
7. Feng S.S., and Chien S. Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chemical Engineering Science 58 (2003) 4087-4114
8. Feng S.S., and Huang G.F. Effects of phospholipids as emulsifiers on controlled release of paclitaxel from nanospheres of biodegradable polymers. Journal of Controlled Release 71 (2001) 53-69
9. Feng S.S., Mu L., Win K.Y., and Huang G.H. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Current Medicinal Chemistry 11 (2004) 413-424
10. Gelderblom H., Verweij J., Nooter K., and Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. European Journal of Cancer 37 (2001) 1590-1598
11. Huizing M.T., Misser V.H., Pieters R.C., ten-Bokkel-Huinink W.W., Veenhof C.H., Vermorken J.B., Pinedo H.M., and Beijnen J.H. Taxanes: a new class of antitumor agents. Cancer Investigation 13 (1995) 381-404
12. Kaul G., and Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharmaceutical Research 22 (2005) 951-961
13. Kim S.Y., Le Y.M., Baik D.J., and Kang J.S. Toxic characteristics of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) nanospheres; in vitro and in vivo studies in the normal mice. Biomaterials 24 (2003) 55-63
14. Liebmann J., Cook J.A., Lipschultz C., Teague D., Fisher J., and Mitchell J.B. Cytotoxic study of paclitaxel (Taxol) in human tumor-cell lines. British Journal of Cancer 68 (1993) 1104-1109
15. Mu L., and Feng S.S. Vitamin E TPGS used as emulsifier in the solvent extraction/evaporation technique for fabrication of polymeric nanospheres for controlled release of paclitaxel. Journal of Controlled Release 80 (2002) 129-144
16. ®): PLGA nanoparticles containing vitamin E TPGS. Journal of Controlled Release 86 (2003) 33-48
17. Mu L., and Feng S.S. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and the drug loading ratio. Pharmaceutical Research 20 (2003) 1864-1872
18. Panchagnula R. Pharmaceutical aspects of paclitaxel. International Journal of Pharmaceutics 172 (1998) 1-15
19. Sahoo S.K., Panyam J., Prabha S., and Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of Controlled Release 82 (2002) 105-114
20. Service R.F. Nanotechnology takes aim at cancer. Science 310 (2005) 1132-1134
21. Singla A.K., Garg A., and Aggarwal D. Paclitaxel and its formulations. International Journal of Phamaceutics 235 (2002) 179-192
22. Shabbits J.A., Chiu G.N.C., and Mayer L.D. Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems. Journal of Controlled Release 84 (2002) 161-170
23. Spencer A.T., and Faulds D. Paclitaxel-a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 48 (1994) 794-847
24. US Department of Health and Services, National Institute of Health (NIH), National Cancer Institute (NCI), 2004. Cancer nanotechnology: going small for big advances. 〈http://www.nih.com〉.
25. Wani M.C., Taylor H.L., Wall M.E., Coggon P., and McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus Brevifolia. Journal of the American Chemical Society 93 (1971) 2325-2327
26. Weiss, R.B., Donehower, R.C., Wiernik, P.H., Ohnuma, T., Gralla, R.J., Trump, D.L., Baker, Jr., Van Echo, D.A., Von Hoff, D.D., Leyland-Jones, B., 1990. Hypersensitivity reactions from Taxol. Journal of Clinical Oncology 8, 1263-1268.
27. Win K.Y., and Feng S.S. Studies on vitamin E TPGS-emulsified poly(D,L-lactic-co-glycolic acid) nanoparticles for clinical administration of paclitaxel. Biomaterials 27 (2006) 2285-2291
28. Win K.Y., and Feng S.S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26 (2005) 2713-2722